
Dotvery MF 80mg/250mg Tablet
Marketer
Biodiscovery Lifesciences Pvt Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Dotvery MF 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, Dolfin MF 80mg/250mg Tablet. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Administered with food, the dosage and duration of Dolfin MF 80mg/250mg Tablet are determined by your physician, based on your response and condition. Continuous use, as directed, is crucial; premature discontinuation may result in symptom recurrence and condition exacerbation. Inform your healthcare provider about all concurrent medications, as interactions are possible. Common, generally transient, side effects include diarrhea, nausea, vomiting, stomach ache, dry mouth, appetite suppression, thirst, and heartburn. Report any concerns to your doctor immediately. Dizziness and drowsiness are also potential side effects; refrain from driving or mentally demanding tasks until their impact is assessed. Alcohol consumption should be avoided due to potential dizziness exacerbation. Prior to commencing treatment, disclose any pregnancy, pregnancy plans, breastfeeding, kidney, or liver conditions to allow for appropriate dosage adjustment.
Primary Ingredients of Dotvery MF 80mg/250mg Tablet
No text provided to rephrase.
Uses of Dotvery MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Dotvery MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 80mg/250mg Dotvery MF Tablet whole; do not crush, chew, or divide it. Administer this medicine with food.
Common Side effects of Dotvery MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Dotvery MF 80mg/250mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dotvery MF 80mg/250mg tablets with food.
How Dotvery MF 80mg/250mg Tablet works:
Each Dotvery MF 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, reducing contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of pain- and inflammation-causing substances, thus reducing abdominal swelling and pain.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Dotvery MF 80mg/250mg Tablet should not be consumed together due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Dotvery MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Dotvery MF 80mg/250mg Tablet with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Dotvery MF 80mg/250mg Tablets, a potential side effect of this medication, including the possibility of dizziness.
KidneyCAUTION
Exercise caution when administering Dotvery MF 80mg/250mg tablets to individuals with kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Dotvery MF 80mg/250mg tablets are contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
The use of Dotvery MF 80mg/250mg tablets requires careful consideration in individuals with hepatic impairment. Dosage modification of Dotvery MF 80mg/250mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Dotvery MF 80mg/250mg Tablet :
Should you forget a Dotvery MF 80mg/250mg Tablet dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Dotvery MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
